Skip to main content
Veterinary Medicines

MILBEMAX 16 MG/40 MG FILM-COATED TABLETS FOR CATS

Authorised
  • Milbemycin oxime
  • Praziquantel

Product identification

Medicine name:
MILBEMAX 16 MG/40 MG FILM-COATED TABLETS FOR CATS
MILBEMAX 16 MG/40 MG COMPRIMES PELLICULES POUR CHATS
Active substance:
  • Milbemycin oxime
  • Praziquantel
Target species:
  • Cat
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Milbemycin oxime
    16.00
    milligram(s)
    /
    1.00
    Tablet
  • Praziquantel
    40.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Film-coated tablet
Withdrawal period by route of administration:
  • Oral use
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP54AB51
Authorisation status:
  • Valid
Authorised in:
  • France
Available in:
  • France
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Elanco GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Elanco France S.A.S
Responsible authority:
  • French Agency For Food, Environmental And Occupational Health & Safety
Authorisation number:
  • FR/V/6980943 5/2002
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0135/004
Concerned member states:
  • Austria
  • Belgium
  • Cyprus
  • Czechia
  • Denmark
  • Finland
  • Germany
  • Greece
  • Hungary
  • Ireland
  • Italy
  • Luxembourg
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 14/02/2025

Package Leaflet and Labelling

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 7/02/2025

Combined File of all Documents

English (PDF)
Published on: 26/02/2025
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."